Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline – Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 25, 2026 to file lead plaintiff applications in a securities class action lawsuit against Futu Holdings Limited (“Futu” or the “Company”) (NasdaqGM: FUTU), if they purchased or otherwise acquired the Company’s securities between May 24, 2023 and May 27, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased securities of Futu as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgm-futu/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by August 25, 2026.

>>>

CLICK HERE

for more information

About the Lawsuit

Futu and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company was not in compliance with the requirements of the China Securities Regulatory Commission, including because it continued to conduct securities business, public fund sales business and futures business in mainland China without obtaining the requisite licenses or approval; (ii) as a result, the Company was reasonably likely to face regulatory penalties, including the disgorgement of ill-gotten gains and other penalties; (iii) as a result of the foregoing, the Company’s financial results were overstated; and (iv) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

The case is Tang v. Futu Holdings Limited, et al, 26-cv-05453.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



AeroVironment, Inc. Notice of July 27, 2026 Application Deadline for Class Action Lawsuits – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in AeroVironment, Inc. (“AeroVironment” or the “Company”) (NasdaqGS: AVAV) of class action securities lawsuits.

CLASS DEFINITION: The lawsuits seek to recover losses on behalf of investors of AeroVironment, Inc. who were adversely affected if they purchased the Company’s securities between 4:30 PM on June 24, 2025 and June 18, 2026, both dates inclusive (the “Class Period”). These actions are pending in the United States District Courts for the Eastern District of Virginia and District of Delaware.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-avav/

AeroVironment investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-avav/ to learn more.


CLICK HERE

for more information

CASE DETAILS: According to the Complaints, AeroVironment and certain of its executives are charged with failing to disclose material information during the class period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the U.S. Space Force’s Satellite Communication Augmentation Resource program and the U.S. Space Force’s ongoing efforts to modernize the Satellite Control Network; (ii) accordingly, defendants overstated AeroVironment’s business and financial prospects; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

The first-filed case is Norrell v. AeroVironment, Inc., et al, No. 26-cv-01429. A subsequent case, City Pension Fund for Firefighters and Police Officers in the City of Miami Beach v. AeroVironment, Inc. et al., No. 26-cv-00875, expanded the class period.

WHAT TO DO? If you invested in AeroVironment and suffered a loss during the relevant time frame, you have until July 27, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. (“Erasca” or the “Company”) (NasdaqGS: ERAS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Erasca, Inc. who were adversely affected if they purchased the Company’s shares between January 14, 2025 and April 26, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-eras/

Erasca investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-eras/ to learn more.


CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Erasca and certain of its executives are charged with failing to disclose material information during the class period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the preclinical data for the Company’s ERAS-0015 product, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors, was based on improper comparisons to Revolution Medicines, Inc. and placed Erasca at risk of violating patent and trade secret protections; and (ii) based on the foregoing, the defendants lacked a reasonable basis for their positive statements related to ERAS-0015.

The case is Cheng v. Erasca, Inc., No. 26-cv-03481.

WHAT TO DO? If you invested in Erasca and suffered a loss during the relevant time frame, you have until August 10, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ADMA Biologics, Inc. (“ADMA” or the “Company”) (NasdaqGM: ADMA) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of ADMA Biologics, Inc. who were adversely affected if they purchased the Company’s securities between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgm-adma/?prs=globe

ADMA investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgm-adma/?prs=globe to learn more.


CLICK HERE

for more information

CASE DETAILS: According to the Complaint, ADMA Biologics and certain of its executives are charged with failing to disclose material information in the Offering Documents, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company engaged in an undisclosed related party transaction; (ii) the Company used channel stuffing to create an appearance of revenue; (iii) the Company lacked adequate internal controls; (iv) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

The case is Mazzarino v. ADMA Biologics, Inc., et al, No. 26-cv-04793.

WHAT TO DO? If you invested in ADMA and suffered a loss during the relevant time frame, you have until August 10, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn



Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

-Reverse stock split to support continued compliance with NYSE American continued listing standards-

TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world’s first and only total artificial heart approved by both the U.S. Food and Drug Administration (“FDA”) and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Stock Split”). As disclosed in the Company’s Current Report on Form 8-K filed on July 21, 2026, the Company’s stockholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation at the annual meeting of the stockholders held on July 17, 2026, authorizing a reverse stock split of the Company’s common stock at a ratio in the range of 1-for-15 to 1-for-50, with the ratio, implementation and timing to be determined by the Board in its sole discretion. The Board subsequently determined to effect the Reverse Stock Split at a ratio of 1-for-50.

The Reverse Stock Split is expected to become effective at 5:00 p.m. Eastern Time on July 31, 2026, with the Company’s common stock expected to begin trading on a split-adjusted basis at the opening of trading on August 3, 2026 under the existing NYSE American ticker symbol, “PMI” with a new CUSIP number of 71953R 207.

At the effective time of the Reverse Stock Split, every fifty (50) issued and outstanding shares of the Company’s common stock will automatically be combined into one (1) issued and outstanding share of common stock for stockholders of record as of the close of trading on July 31, 2026, the effective date. The Reverse Stock Split will proportionately reduce the number of outstanding shares of common stock while leaving each stockholder’s percentage ownership in the Company substantially unchanged, subject to the treatment of fractional shares.

No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive a fractional share as a result of the Reverse Stock Split will have their shares rounded up to the nearest whole share. The Reverse Stock Split will proportionately adjust the number of shares of common stock underlying the Company’s outstanding equity awards, warrants and other convertible securities, as well as the applicable exercise or conversion prices, in accordance with their respective terms.

“The Reverse Stock Split is an important step in supporting our continued listing on NYSE American while positioning Picard Medical for our next phase of growth,” said Richard Fang, Interim Chief Executive Officer and Chairman of the Board. “We remain focused on executing on our updated commercial strategy for the SynCardia Total Artificial Heart, expanding adoption of this technology while optimizing our manufacturing, advancing the development of the Emperor, next-generation total artificial heart platform, and pursuing opportunities to create long-term value for our stockholders.”

The Company’s transfer agent, Continental Stock Transfer & Trust Company, will act as exchange agent for the Reverse Stock Split. Stockholders holding shares electronically through a brokerage account or in book-entry form are not required to take any action to receive their post-split shares.

About Picard Medical and SynCardia

Picard Medical, Inc. is the parent company of SynCardia Systems, LLC (“SynCardia”), the Tucson, Arizona–based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (“STAH”), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the STAH is the most widely used and extensively studied artificial heart in the world. For additional information about Picard Medical, please visit www.picardmedical.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Forward-looking statements can often be identified by words such as “will,” “continue,” “goal,” “advance,” “intended,” and “designed to,” and similar expressions, and various or negatives of these words. These statements include, but are not limited to, statements regarding timing and implementation of the Reverse Stock Split, Picard Medical’s next phase of growth, advancing development of our next generation fully implantable total artificial heart platform, executing commercial strategy for and expanding adoption of, the STAH, and pursuing opportunities to create long-term value for our stockholders. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Additional information about the Company, including risk factors that may affect the Company’s business, financial condition, and results of operations, is contained in the Company’s filings with the SEC, including the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are available free of charge on the SEC’s website at http://www.sec.gov and on the Company’s investor relations website at https://picardmedical.com/.

Contact:

Investors
Eric Ribner
Managing Director
LifeSci Advisors LLC
[email protected]

Picard Medical, Inc./SynCardia Systems, LLC
[email protected]

General/Media
Brittany Lanza
[email protected]



Labaton Keller Sucharow LLP Files Securities Class Action Against Primoris Services Corporation

Labaton Keller Sucharow LLP Files Securities Class Action Against Primoris Services Corporation

NEW YORK–(BUSINESS WIRE)–Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Action”) on behalf of its clients Boston Retirement System (“Boston”) and NS Pension Public Equity Fund (“NS Pension”) against Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM) and certain Primoris officers and directors (collectively, “Defendants”). The Action, which is captioned Boston Retirement System v. Primoris Services Corp., No. 26-cv-02416-B (N.D. Tex.), asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder on behalf of all persons and entities that purchased or otherwise acquired Primoris common stock between August 5, 2025 and June 22, 2026, inclusive (the “Class Period”).

Primoris is an infrastructure services company that provides engineering, procurement, construction, and maintenance services to customers in the utilities, energy, and infrastructure markets. During the Class Period, Primoris’ Energy segment generated a majority of the Company’s revenue, with its renewable energy business serving as a significant contributor. Because Primoris performed much of its renewable energy work under fixed-price construction contracts, its profitability depended on accurately estimating project costs and controlling expenses, as the Company generally bore the risk of cost overruns.

The Action alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding Primoris’ cost estimation, cost-to-complete forecasting, project execution, ability to manage project risk, financial performance, and financial guidance because Defendants knew or recklessly disregarded that: (i) Primoris’ cost estimation, cost-to-complete forecasting, and project oversight processes were deficient and failed to provide reliable estimates of the costs and expected profitability of significant fixed-price renewable energy projects; (ii) as a result, Primoris systematically underestimated the costs and risks of significant fixed-price renewable energy projects that were experiencing material cost overruns, execution problems, and schedule delays; and (iii) accordingly, Defendants’ statements regarding the Company’s estimating processes, project execution, ability to manage project risk, financial performance, and financial guidance lacked a reasonable basis and omitted material adverse facts.

The truth was revealed through a series of disclosures between February 23, 2026 and June 22, 2026, culminating in Primoris’ announcement that an ongoing internal review, supported by an independent third-party industry expert, had identified significant cost overruns, project delays, and execution challenges affecting six renewable energy projects. The Company disclosed materially lower expected Renewables revenue for 2026, sharply reduced its full-year 2026 financial guidance, and announced the resignation of its Chief Operating Officer. On this news, Primoris’ stock price fell 21.6%, from $108.34 per share to $84.95 per share.

If you purchased or acquired Primoris common stock during the Class Period and were damaged thereby, you are a member of the “Class” and may be able to seek appointment as Lead Plaintiff. Lead Plaintiff motion papers must be filed no later than September 21, 2026. The Lead Plaintiff is a court-appointed representative for absent members of the Class. You do not need to seek appointment as Lead Plaintiff to share in any Class recovery in this action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. You may retain counsel of your choice to represent you in this action.

If you would like to consider serving as Lead Plaintiff or have any questions about this lawsuit, you may contact Connor C. Boehme, Esq. of Labaton at +1 (212) 907-0780, or via email at [email protected]. You can view a copy of the Complaint online here.

Boston and NS Pension are represented by Labaton, which represents many of the largest pension funds in the United States and internationally with combined assets under management of more than $6 trillion. Labaton’s litigation reputation is built on its half-century of securities litigation experience, more than ninety full-time attorneys, and in-house team of investigators, financial analysts, and forensic accountants. Labaton has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, Delaware, London, and Washington, D.C. More information about Labaton is available at labaton.com.

Connor C. Boehme, Esq.
Labaton Keller Sucharow LLP
+1 (212) 907-0780
[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

AirJoule Technologies and Kubota Corporation Announce Deployments of Breakthrough Decentralized Water Infrastructure and Exclusive Sales Partnership to Unlock Water-Constrained U.S. Residential Development

Kubota to begin initial deployments of AirJoule water-from-air systems and serve as exclusive sales channel for multi-unit residential developments in Texas and California

RONAN, Mont. and OSAKA, Japan, July 21, 2026 (GLOBE NEWSWIRE) — AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or “AIRJ”), a leading technology platform that unleashes the power of water from air, and Kubota Corporation (TYO: 6326) (“Kubota”), a global leader in water and environmental infrastructure solutions, today announced an initial deployment of AirJoule Technologies’ breakthrough water-from-air technology in Texas and California, as well as an exclusive sales agreement for multi-unit residential developments.

Through the collaboration, Kubota will evaluate the AirJoule atmospheric water generation technology as a key component of a decentralized water circulation infrastructure that can produce, treat and reuse water within local communities, particularly for residential developments in regions of the U.S. facing water scarcity or water quality constraints.

Pursuant to the exclusive sales agreement, Kubota will market, sell, and distribute AirJoule systems for multi-unit residential developments in the initial territories of Texas and California. The parties may consider broader commercial collaboration based on the results of the initial deployments, customer needs, and the feasibility of integrating AirJoule systems with Kubota’s wastewater reclamation equipment and digital infrastructure capabilities.

Kubota has purchased two AirJoule Core systems for initial deployments at sites near Corpus Christi, Texas and Irvine, California. Both deployments are expected to begin in Q3 2026 and will pair AirJoule atmospheric water generation technology with Kubota’s water infrastructure expertise, including wastewater treatment, water reclamation, pipe systems and operation and maintenance capabilities. The deployments will also generate operational data to validate AirJoule’s performance across a range of environmental conditions relevant to residential water supply, helping to accelerate commercial adoption.

The partnership positions both AIRJ and Kubota at the forefront of addressing one of the most pressing challenges facing residential developers today: securing reliable water resources in areas where traditional infrastructure is either cost-prohibitive or unavailable. AirJoule’s industry-leading operational window and energy utilization profile are designed to support residential developments across the U.S. Southwest, from the Gulf Coast to the California hills, where water scarcity has reached record levels.

Management Commentary

“This partnership with Kubota represents an important milestone as we commercialize AirJoule,” said Matt Jore, Chief Executive Officer of AirJoule Technologies. “Kubota is a globally recognized leader in water and environmental infrastructure with strong experience supporting residential developments in water-constrained areas. By partnering with Kubota on the initial deployments in Texas and California and for residential development sales, we are well-positioned to capture significant market share while solving a critical societal challenge: providing clean, reliable water to communities that need it most.”

“The feedback we’ve received from residential developers has been clear: there is urgent, substantial demand for solutions that can provide reliable water without the constraints of traditional infrastructure,” said Wataru Kondo, Director, Senior Managing Executive Officer, and General Manager of Water and Environment Infrastructure Consolidated Company at Kubota Corporation. “The AirJoule technology, combined with our water reclamation systems and smart infrastructure platform, positions us to deliver a complete, integrated solution that transforms how communities access and manage water. We see significant near-term demand from our developer network and expect this partnership to serve as a platform for broader deployment across the United States.”

Addressing Critical Infrastructure Challenges and Regulatory Drivers

The collaboration between AirJoule Technologies and Kubota targets several key challenges identified by residential developers operating in water-constrained markets:

  • Regulatory Compliance: In some western states, such as California, developers planning residential communities of a certain size must demonstrate 20-year water resource security to obtain permits—a requirement that has significantly constrained new development. AIRJ and Kubota envision an integrated solution designed to enable developers to meet these regulatory requirements without reliance on traditional water sources.
  • Water Quality and Drinking Water Standards: AirJoule Technologies and Kubota are committed to delivering the highest quality drinking water to residential customers. The AirJoule platform produces water that meets the most stringent U.S. drinking water requirements, including those set by the state of California.
  • Infrastructure Cost Avoidance: Extending water pipes from centralized treatment facilities can cost millions of dollars and delay projects by years. AIRJ and Kubota’s decentralized approach eliminates these infrastructure barriers, enabling development in previously unbuildable locations.
  • Water Resource Uncertainty: Developers across the southwest United States, including Texas and Arizona, face challenges ranging from groundwater depletion to contamination (including high nitrate and arsenic levels and seawater intrusion). AirJoule offers a climate-independent, reliable water source that does not deplete aquifers or compete for existing water rights.

About AirJoule Technologies Corporation

AirJoule Technologies Corporation (NASDAQ: AIRJ) is a leading technology platform that unleashes the power of water from air. Through its joint venture with GE Vernova and in partnership with Carrier Global Corporation, the company’s purpose is freeing the world of its water and energy constraints by delivering groundbreaking sorption technologies. For more information, visit https://airjouletech.com.

Follow AirJoule Technologies on LinkedIn: https://www.linkedin.com/company/airjoule-tech/

About Kubota Corporation

Since its founding in 1890, the Kubota Group has been working to solve social issues through superior products, technologies, and services in the areas of food, water, and the environment. We operate in more than 150 countries around the world, providing solutions to enhance the productivity and safety of food, promote the circulation of water resources and waste, and improve urban and living environments. Under our brand statement “For Earth, For Life,” we promise to continue supporting the prosperous life of humans while protecting the environment of this beautiful earth.

For more information on the Kubota group, please visit: https://www.kubota.com/.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this press release, regarding AirJoule Technologies and its future financial and operational performance, as well as its strategy, future operations, estimated financial position, estimated revenues, and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this press release, including any oral statements made in connection therewith, the words “may,” “should,” “will,” “expect,” “might,” “plan,” “anticipate,” “could,” “intend,” “target,” “goal,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “positioned,” “seek,” “would” or “continue” ” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, AirJoule Technologies expressly disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements herein, to reflect events or circumstances after the date of this press release.

AirJoule Technologies cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond AirJoule Technologies’ control. These risks include, but are not limited to, our ability to implement business plans and forecasts, including the ability to develop, deploy and commercialize our technology and equipment, risks related to our arrangements with strategic partnerships and other third parties, the availability and cost of materials needed to develop, deploy and commercialize our technology and equipment, our status as an early stage company with limited operating history, and the other risks and uncertainties described in our SEC filings including the “Risk Factors” section of our most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Should one or more of the risks or uncertainties described in this presentation occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statementsAirJoule Technologies’ SEC Filings are available publicly on the SEC’s website at www.sec.gov, and readers are urged to carefully review and consider the various disclosures made in such filings.

Trademark Protection

AirJoule Technologies’ name, logos and website name and address are trademarks or service marks. Solely for convenience, in some cases, the trademarks, trade names and service marks referred to in this press release are listed without the applicable®,™ and SM symbols, but AirJoule Technologies will assert, to the fullest extent under applicable law, its rights to these trademarks, trade names and service marks.


Contacts

AirJoule Technologies:

Investor Relations & Media:

Tom Divine – Vice President, Investor Relations and Finance
[email protected]

Kubota Corporation:

Media:

Corporate Service Dept – KUBOTA Water and Environment U.S.A Corporation
[email protected]



Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. – PSNL

Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. – PSNL

NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Personalis, Inc. (NasdaqGM: PSNL) to Tempus AI, Inc. (NasdaqGS: TEM). Under the terms of the proposed transaction, shareholders of Personalis will receive $16.25 per common share. The consideration is reported to be structured as a 100% stock transaction, with Tempus having the option to elect payment in cash at Tempus’ discretion, capped at 50% of the consideration paid. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at (833) 538-3612, or visit https://www.ksfcounsel.com/cases/nasdaqgm-psnl/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 960
New Orleans, LA 70163
Lewis S. Kahn
Managing Partner
[email protected]
(833) 538-3612

KEYWORDS: Louisiana New York United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

Utz Brands Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Utz Brands, Inc. – UTZ

Utz Brands Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Utz Brands, Inc. – UTZ

NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Utz Brands, Inc. (NYSE: UTZ) to Intersnack Group GmbH & Co. KG. Under the terms of the proposed transaction, shareholders of Utz will receive $14.25 in cash for each share of Utz that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at (833) 538-3612, or visit https://www.ksfcounsel.com/cases/nyse-utz/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Kahn Swick & Foti, LLC

Lewis S. Kahn

[email protected]

855-768-1857

1100 Poydras St., Suite 960

New Orleans, LA 70163

KEYWORDS: Louisiana New York United States North America

INDUSTRY KEYWORDS: Professional Services Class Action Lawsuit

MEDIA:

Logo
Logo

LXP Industrial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LXP Industrial Trust – LXP

LXP Industrial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LXP Industrial Trust – LXP

NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of LXP Industrial Trust (NYSE: LXP) to Brookfield Asset Management (NYSE: BAM) and Canada Pension Plan Investment Board. Under the terms of the proposed transaction, shareholders of LXP will receive $61.20 in cash for each share of LXP that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at (833) 538-3612, or visit https://www.ksfcounsel.com/cases/nyse-lxp/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Kahn Swick & Foti, LLC

Lewis S. Kahn

[email protected]

855-768-1857

1100 Poydras St., Suite 960

New Orleans, LA 70163

KEYWORDS: Louisiana New York United States North America

INDUSTRY KEYWORDS: Professional Services Class Action Lawsuit

MEDIA:

Logo
Logo